NXGN — Nextgen Healthcare Share Price
0.000.00%
Last trade - 00:00TechnologyBalancedMid Cap
- $1.61bn
- $1.67bn
- $653.17m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 19.3 | ||
| PEG Ratio (f) | 0.52 | ||
| EPS Growth (f) | 58.21% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.79 | ||
| Price to Tang. Book | 94.94 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.31 | ||
| EV to EBITDA | 41.68 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 0.39% | ||
| Return on Equity | -1.44% | ||
| Operating Margin | 0.4% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 529.17 | 540.24 | 556.82 | 596.35 | 653.17 | 718.97 | 774.71 | 4.23% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +273.34 | -32.54 | -16.17 | -69.91 | +284.46 | +335.39 | +18.6 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
NextGen Healthcare, Inc. is a provider of cloud-based, healthcare technology solutions that helps ambulatory healthcare providers to manage the risk and complexity of delivering care in the United States healthcare system. Its portfolio includes integrated solutions, which delivers on ambulatory healthcare imperatives, including consumerism, digitization, risk allocation, regulatory influence, and integrated care and health equity. Its solutions deliver care in various medical specialty in a range of practice models, including accountable care organizations (ACOs), independent physician associations (IPAs), managed service organizations (MSOs), veterans service organizations (VSOs) and dental service organizations. It offers services across enterprise, office and insights, which include NextGen Enterprise HER, NextGen Enterprise PM, NextGen Virtual Visit, NextGen Office, NextGen Share and Mirth Connect. It also offers data and analytics solutions, which include NextGen Health Data Hub.
Directors
- Jeffrey Margolis NEC (58)
- Sheldon Razin NEC (83)
- David Sides PRE (51)
- Craig Barbarosh NVC (53)
- James Arnold CFO (65)
- David Metcalfe EVP (58)
- Jeffrey Linton EVP (56)
- Donna Greene EVP (58)
- Lonnie Plunk EVP (50)
- Srinivas Velamoor EVP (46)
- Mitchell Waters EVP (56)
- Robert Murry OTH
- Darnell Dent DRC
- Pamela Puryear DRC (58)
- George Bristol IND (72)
- Julie Klapstein IND (66)
- Geraldine Mcginty IND
- Morris Panner IND (58)
- Lance Rosenzweig IND (59)
- Last Annual
- March 31st, 2023
- Last Interim
- September 30th, 2023
- Incorporated
- April 24th, 1974
- Public Since
- December 1st, 1985
- No. of Shareholders
- 601
- No. of Employees
- 2,783
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- 67,096,894
- Address
- 18111 Von Karman Avenue, IRVINE, 92612
- Web
- https://www.nextgen.com/
- Phone
- +1 9492552600
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for NXGN
Similar to NXGN
2U
NASDAQ Global Select Market
ACV Auctions
NASDAQ Global Select Market
Adeia
NASDAQ Global Select Market
Adobe
NASDAQ Global Select Market
Agilysys
NASDAQ Global Select Market
FAQ
What is the Nextgen Healthcare share price?
As of Today at 06:15 UTC, shares in Nextgen Healthcare are trading at $23.94. This share price information is delayed by 15 minutes.
How has the Nextgen Healthcare share price performed this year?
Shares in Nextgen Healthcare last closed at $23.94 and the price had moved by +18.51% over the past 365 days. In terms of relative price strength the Nextgen Healthcare share price has outperformed the S&P500 Index by +7.18% over the past year.
What are the analyst and broker recommendations for Nextgen Healthcare?
The overall consensus recommendation for Nextgen Healthcare is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Nextgen Healthcare dividend yield?
Nextgen Healthcare does not currently pay a dividend.
Does Nextgen Healthcare pay a dividend?
Nextgen Healthcare does not currently pay a dividend.
When does Nextgen Healthcare next pay dividends?
Nextgen Healthcare does not currently pay a dividend.
How do I buy Nextgen Healthcare shares?
To buy shares in Nextgen Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Nextgen Healthcare?
As of the previous close price of $23.94, shares in Nextgen Healthcare had a market capitalisation of $1.61bn.
Where are Nextgen Healthcare shares listed?
Here are the trading details for Nextgen Healthcare:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: NXGN
What kind of share is Nextgen Healthcare?
Based on an overall assessment of its quality, value and momentum Nextgen Healthcare is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Nextgen Healthcare share price forecast for 2023?
The analyst consensus target price for shares in Nextgen Healthcare is $23.93. That is 0.04% below the last closing price of $23.94.
Analysts covering Nextgen Healthcare currently have a consensus Earnings Per Share (EPS) forecast of $1.11 for the next financial year.
What is the trend in the Nextgen Healthcare share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Nextgen Healthcare. Over the past six months, its share price has outperformed the S&P500 Index by +34.38%.
As of the last closing price of $23.94, shares in Nextgen Healthcare were trading +28.45% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Nextgen Healthcare PE Ratio?
The Nextgen Healthcare PE ratio based on its reported earnings over the past 12 months is 19.3. The shares last closed at $23.94.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Nextgen Healthcare?
Nextgen Healthcare's management team is headed by:
- Jeffrey Margolis - NEC
- Sheldon Razin - NEC
- David Sides - PRE
- Craig Barbarosh - NVC
- James Arnold - CFO
- David Metcalfe - EVP
- Jeffrey Linton - EVP
- Donna Greene - EVP
- Lonnie Plunk - EVP
- Srinivas Velamoor - EVP
- Mitchell Waters - EVP
- Robert Murry - OTH
- Darnell Dent - DRC
- Pamela Puryear - DRC
- George Bristol - IND
- Julie Klapstein - IND
- Geraldine Mcginty - IND
- Morris Panner - IND
- Lance Rosenzweig - IND